IP Library Granted Patent US 8,026,089
Granted Patent B2
US 8,026,089 · App. 12/726,390 · Granted Sep 27, 2011

Mutant Δ8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,089
App. No.
12/726,390
Granted
Sep 27, 2011
Kind
B2
Abstract

The present invention relates to mutant Δ8 desaturase genes, which have the ability to convert eicosadienoic acid [20:2 ω-6, EDA] to dihomo-γ-linolenic acid [20:3, DGLA] and/or eicosatrienoic acid [20:3 ω-3, ETrA] to eicosatetraenoic acid [20:3 ω-3, ETA]. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding Δ8 desaturase along with methods of making long-chain polyunsaturated fatty acids (PUFAs) using these mutant Δ8 desaturases in plants and oleaginous yeast are disclosed.

Claims (31)

1. An isolated polypeptide having Δ8 desaturase activity comprising the amino acid sequence set forth in SEQ ID NO:198, wherein SEQ ID NO:198 is not identical to SEQ ID NO:10.

2. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:2, wherein SEQ ID NO:2 is not identical to SEQ ID NO:10.

3. The polypeptide of claim 1 wherein the Δ8 desaturase activity is at least functionally equivalent to the Δ8 desaturase activity of the polypeptide as set forth in SEQ ID NO:10.

4. The polypeptide of claim 2 wherein the Δ8 desaturase activity is at least functionally equivalent to the Δ8 desaturase activity of the polypeptide as set forth in SEQ ID NO:10.

5. A transformed cell comprising the polypeptide of claim 1 or claim 2 , wherein the transformed cell is selected from the group consisting of a plant cell and a microbial cell.

6. The cell of claim 5 wherein said cell is a yeast.

7. The cell of claim 6 wherein the yeast is an oleaginous yeast producing at least 25% of its dry cell weight as oil.

8. The cell of claim 7 wherein the oleaginous yeast is selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

9. The cell of claim 8 wherein the cell is a Yarrowia lipolytica.

10. A method for making long-chain polyunsaturated fatty acids in a yeast cell comprising:

(a) providing the yeast cell according to claim 6 ; and

(b) growing the yeast cell of (a) under conditions wherein long-chain polyunsaturated fatty acids are produced.

11. The method according to claim 10 wherein the yeast is oleaginous yeast producing at least 25% of its dry cell weight as oil.

12. The method according to claim 11 wherein the yeast is a Yarrowia sp.

13. An oleaginous yeast producing at least 25% of its dry cell weight as oil comprising:

a) the polypeptide according to claim 1 ; and,

b) at least one additional polypeptide selected from the group consisting of: Δ4 desaturase, Δ5 desaturase, Δ6 desaturase, Δ9 desaturase, Δ12 desaturase, Δ15 desaturase, Δ17 desaturase, Δ9 elongase, C 14/16 elongase, C 16/18 elongase, C 18/20 elongase and C 20/22 elongase.

14. The yeast of claim 13 selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

15. The yeast of claim 14 wherein the yeast cell is a Yarrowia sp, and the oil comprises a long-chain polyunsaturated fatty acid selected from the group consisting of: arachidonic acid, eicosadienoic acid, eicosapentaenoic acid, eicosatetraenoic acid, eicosatrienoic acid, dihomo-γ-linolenic acid, docosapentaenoic acid and docosahexaenoic acid.

16. A method for producing a polyunsaturated fatty acid comprising:

a) providing an oleaginous yeast comprising:

(i) a Δ8 desaturase polypeptide having the amino acid sequence as set forth in SEQ ID NO:198, wherein SEQ ID NO:198 is not identical to SEQ ID NO:10; and,

(ii) a source of substrate fatty acid selected from the group consisting of eicosadienoic acid and eicosatrienoic acid;

b) growing the yeast of step (a) under conditions wherein the substrate fatty acid is converted to product polyunsaturated fatty acid, wherein eicosadienoic acid is converted to dihomo-γ-linoleic acid, and eicosatrienoic acid is converted to eicosatetraenoic acid, and;

c) optionally recovering the product polyunsaturated fatty acid of step (b).

17. A method for the production of dihomo-γ-linolenic acid comprising:

a) providing a yeast cell comprising:

(i) the polypeptide according to claim 2 , and;

ii) at least one additional polypeptide having Δ9 elongase activity;

b) providing the yeast cell of (a) with a source of linolenic acid, and;

c) growing the yeast cell of (b) under conditions wherein dihomo-γ-linolenic acid is formed.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →